Skip to main content

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Investor Securities Class Action Lawsuit 10/15/2020

  • If you purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 27, 2021 - The case was voluntarily dismissed. October 15, 2020 - An investor in shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) filed a lawsuit in the U.S. District Court for the Eastern District of Texas over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between Oc...

You must register (for free) or login to view the entire case.